WALLIX GROUP(EPA:ALLIX) stock Fundamental Analysis

Fundamental Rating

ALLIX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 100 industry peers in the Software industry. Both the profitability and financial health of ALLIX have multiple concerns. ALLIX is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALLIX had negative earnings in the past year.

ALLIX had a negative operating cash flow in the past year.

In the past 5 years ALLIX always reported negative net income.

ALLIX had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

ALLIX's Return On Assets of -16.96% is on the low side compared to the rest of the industry. ALLIX is outperformed by 77.00% of its industry peers.

ALLIX's Return On Equity of -96.25% is on the low side compared to the rest of the industry. ALLIX is outperformed by 79.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-16.96%
ROE	-96.25%
ROIC	N/A

ROA(3y)-10.65%

ROA(5y)-11.63%

ROE(3y)-34.58%

ROE(5y)-30.79%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALLIX's Gross Margin of 109.63% is amongst the best of the industry. ALLIX outperforms 98.00% of its industry peers.

ALLIX's Gross Margin has been stable in the last couple of years.

ALLIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	109.63%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.32%

GM growth 5Y-1.26%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALLIX has more shares outstanding than it did 1 year ago.

ALLIX has more shares outstanding than it did 5 years ago.

The debt/assets ratio for ALLIX is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.16, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.

ALLIX has a Altman-Z score of 0.16. This is in the lower half of the industry: ALLIX underperforms 76.00% of its industry peers.

A Debt/Equity ratio of 0.90 indicates that ALLIX is somewhat dependend on debt financing.

With a Debt to Equity ratio value of 0.90, ALLIX is not doing good in the industry: 77.00% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	0.9
Debt/FCF	N/A
Altman-Z	0.16

ROIC/WACCN/A

WACC7.96%

2.3 Liquidity

ALLIX has a Current Ratio of 0.90. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.

ALLIX's Current ratio of 0.90 is on the low side compared to the rest of the industry. ALLIX is outperformed by 71.00% of its industry peers.

ALLIX has a Quick Ratio of 0.90. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.

ALLIX's Quick ratio of 0.90 is on the low side compared to the rest of the industry. ALLIX is outperformed by 68.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.9
Quick Ratio	0.9

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALLIX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.57%.

Looking at the last year, ALLIX shows a quite strong growth in Revenue. The Revenue has grown by 11.73% in the last year.

Measured over the past years, ALLIX shows a quite strong growth in Revenue. The Revenue has been growing by 19.01% on average per year.

EPS 1Y (TTM)-9.57%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-5.66%

Revenue 1Y (TTM)11.73%

Revenue growth 3Y14.56%

Revenue growth 5Y19.01%

Sales Q2Q%8.67%

3.2 Future

ALLIX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.05% yearly.

Based on estimates for the next years, ALLIX will show a quite strong growth in Revenue. The Revenue will grow by 16.53% on average per year.

EPS Next Y26.32%

EPS Next 2Y43.44%

EPS Next 3Y41.65%

EPS Next 5Y36.05%

Revenue Next Year13.12%

Revenue Next 2Y17.42%

Revenue Next 3Y19.6%

Revenue Next 5Y16.53%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALLIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

With a Price/Forward Earnings ratio of 257.93, ALLIX can be considered very expensive at the moment.

ALLIX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALLIX is more expensive than 65.00% of the companies in the same industry.

ALLIX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.43, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	257.93

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

A more expensive valuation may be justified as ALLIX's earnings are expected to grow with 41.65% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y43.44%

EPS Next 3Y41.65%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALLIX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

WALLIX GROUP

EPA:ALLIX (5/20/2025, 7:00:00 PM)

15.94

+0.28 (+1.79%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)03-20 2025-03-20/amc

Earnings (Next)07-17 2025-07-17

Inst Owners14.85%

Inst Owner ChangeN/A

Ins Owners19.83%

Ins Owner ChangeN/A

Market Cap106.16M

Analysts84

Price Target17.85 (11.98%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)16.67%

PT rev (3m)29.63%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-2.71%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	257.93
P/S	3.38
P/FCF	N/A
P/OCF	N/A
P/B	11.75
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-1.34

EYN/A

EPS(NY)0.06

Fwd EY0.39%

FCF(TTM)-1.4

FCFYN/A

OCF(TTM)-0.62

OCFYN/A

SpS4.71

BVpS1.36

TBVpS-1.5

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-16.96%
ROE	-96.25%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	109.63%
FCFM	N/A

ROA(3y)-10.65%

ROA(5y)-11.63%

ROE(3y)-34.58%

ROE(5y)-30.79%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.32%

GM growth 5Y-1.26%

F-Score2

Asset Turnover0.61

Health

		Industry Rank	Sector Rank
Debt/Equity	0.9
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	124.6%
Cap/Sales	16.54%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.9
Quick Ratio	0.9
Altman-Z	0.16

F-Score2

WACC7.96%

ROIC/WACCN/A

Cap/Depr(3y)146.9%

Cap/Depr(5y)151.4%

Cap/Sales(3y)21.46%

Cap/Sales(5y)23.36%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-9.57%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-5.66%

EPS Next Y26.32%

EPS Next 2Y43.44%

EPS Next 3Y41.65%

EPS Next 5Y36.05%

Revenue 1Y (TTM)11.73%

Revenue growth 3Y14.56%

Revenue growth 5Y19.01%

Sales Q2Q%8.67%

Revenue Next Year13.12%

Revenue Next 2Y17.42%

Revenue Next 3Y19.6%

Revenue Next 5Y16.53%

EBIT growth 1Y-6.17%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year34.48%

EBIT Next 3Y41.41%

EBIT Next 5YN/A

FCF growth 1Y-98.62%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-310.3%

OCF growth 3YN/A

OCF growth 5YN/A

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens